Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial.
Moya J, Temech M, Parra S, Juarez E, Hernandez-Loy R, Gutierrez JCM, Diaz J, Hussain R, Segal S, Xu C, Skingsley A, Schnell G, El-Zailik A, Sager JE, Aldinger M, Alexander EL, Acloque G. Moya J, et al. Among authors: parra s. Open Forum Infect Dis. 2023 Jul 10;10(7):ofad344. doi: 10.1093/ofid/ofad344. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37520411 Free PMC article.
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Rodrigues Falci D, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Parra S, Sager JE, Austin D, Peppercorn A, Alexander E, Yeh WW, Brinson C, Aldinger M, Shapiro AE; COMET-ICE Investigators. Gupta A, et al. Among authors: parra s. JAMA. 2022 Apr 5;327(13):1236-1246. doi: 10.1001/jama.2022.2832. JAMA. 2022. PMID: 35285853 Free PMC article. Clinical Trial.
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Shapiro AE, Sarkis E, Acloque J, Free A, Gonzalez-Rojas Y, Hussain R, Juarez E, Moya J, Parikh N, Inman D, Cebrik D, Nader A, Noormohamed N, Wang Q, Skingsley A, Austin D, Peppercorn A, Agostini ML, Parra S, Chow S, Mogalian E, Pang PS, Hong DK, Sager JE, Yeh WW, Alexander EL, Gaffney LA, Kohli A. Shapiro AE, et al. Among authors: parra s. Open Forum Infect Dis. 2023 Jul 14;10(8):ofad354. doi: 10.1093/ofid/ofad354. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37577112 Free PMC article.
Differential analysis of lipoprotein and glycoprotein profiles in bacterial infections and COVID-19 using proton nuclear magnetic resonance and machine learning.
Iftimie S, Amigó N, Martínez-Micaelo N, López-Azcona AF, Martínez-Navidad C, Castañé H, Jiménez-Franco A, Ribalta J, Parra S, Castro A, Camps J, Joven J. Iftimie S, et al. Among authors: parra s. Heliyon. 2024 Aug 28;10(17):e37115. doi: 10.1016/j.heliyon.2024.e37115. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286163 Free PMC article.
Colombian surgical outcomes study insights on perioperative mortality rate, a main indicator of the lancet commission on global surgery - a prospective cohort study.
Pérez Rivera CJ, Lozano-Suárez N, Velandia-Sánchez A, Vargas-Cuellar MP, Rojas-Serrano LF, Polanía-Sandoval CA, Lara-Espinosa D, García-Zambrano L, Bohórquez-Tarazona MP, Agudelo-Mendoza SV, Cabrera-Rivera PA, Briceno-Ayala L; ColSOS Collaborative. Pérez Rivera CJ, et al. Lancet Reg Health Am. 2024 Aug 20;38:100862. doi: 10.1016/j.lana.2024.100862. eCollection 2024 Oct. Lancet Reg Health Am. 2024. PMID: 39253707 Free PMC article.
Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia.
Saballs M, Parra S, Martínez N, Amigo N, Cabau L, Iftimie S, Pavon R, Gabaldó X, Correig X, Paredes S, Vallvé JM, Castro A. Saballs M, et al. Among authors: parra s. J Lipid Res. 2024 Sep;65(9):100622. doi: 10.1016/j.jlr.2024.100622. Epub 2024 Aug 21. J Lipid Res. 2024. PMID: 39154734 Free PMC article.
Comparative toxicological analysis of two pristine carbon nanomaterials (graphene oxide and aminated graphene oxide) and their corresponding degraded forms using human in vitro models.
de la Parra S, Fernández-Pampín N, Garroni S, Poddighe M, de la Fuente-Vivas D, Barros R, Martel-Martín S, Aparicio S, Rumbo C, Tamayo-Ramos JA. de la Parra S, et al. Toxicology. 2024 May;504:153783. doi: 10.1016/j.tox.2024.153783. Epub 2024 Mar 20. Toxicology. 2024. PMID: 38518840 Free article.
211 results